Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Contraception in the perimenopause

M Sparrow

    Current Therapeutics
    |December 1, 1992
    PubMed
    Summary

    No abstract available in PubMed .

    Keywords:
    Barrier MethodsCoitus InterruptusCondomContraceptionContraceptive AgentsContraceptive Agents, FemaleContraceptive Agents, PostcoitalContraceptive Agents, ProgestinContraceptive MethodsDepo-proveraDiseasesFamily PlanningFamily Planning, Behavioral MethodsIudLiterature ReviewMedroxyprogesterone AcetateMenopauseNatural Family PlanningOral ContraceptivesOral Contraceptives, CombinedProgestins, Low-doseReproductionSigns And SymptomsSterilization, SexualVaginal Barrier MethodsVaginal Spermicides

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Review article: consensus statements on therapeutic drug monitoring of anti-tumour necrosis factor therapy in inflammatory bowel diseases.

    Alimentary pharmacology & therapeutics·2017
    Same author

    Conflict of interest: real and perceived--a more mature consideration is needed.

    Internal medicine journal·2016
    Same author

    Faecal calprotectin: current usage and perceived beneficial effects of third-party funding on rates of colonoscopy by Australian gastroenterologists.

    Internal medicine journal·2016
    Same author

    Systematic review: new serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes.

    Autoimmunity reviews·2014
    Same author

    Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response.

    Internal medicine journal·2014
    Same author

    Setting priorities for comparative effectiveness research in inflammatory bowel disease: results of an international provider survey, expert RAND panel, and patient focus groups.

    Inflammatory bowel diseases·2012